ReviewJournal of lipid and atherosclerosis2024

Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors.

Brian Tomlinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.